TuesdaySep 20, 2022 11:07 am

Scientists Discover Unexpected Way in Which Air Pollution Causes Cancer

Scientists have for the longest time believed that cancer begins to develop when cells in the body acquire more mutations and multiply at an abnormal rate. However, new research has shed light on how air pollution can cause cancer, a discovery that could completely change the understanding of how tumors develop. This study, which was conducted by scientists at the Francis Crick Institute in London, found that air pollution was awakening old damaged cells in the body instead of damaging healthy cells. The investigators, who are also based at University College London, were focused on finding what could trigger the…

Continue Reading

TuesdaySep 20, 2022 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere In September 2022, the company announced it was granted a patent for its 12-lead ECG Patch Monitor, opening a pathway to ischemia and arrhythmia detection innovation in ECG Patch products In August 2022, the company announced it was seeking FDA approval for its HeartBeam AIMI platform technology used to detect and diagnose heart attacks On November 15, 2021, HeartBeam had its IPO on the Nasdaq under ticker symbol ‘BEAT’ The company’s management team has significant experience in software…

Continue Reading

MondaySep 19, 2022 12:00 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Participates in H.C. Wainwright 24th Annual Global Investment Conference, Presenting Key Investor Highlights on Novel Anthracycline Berubicin for GBM Treatment

Glioblastoma multiforme (“GBM”) is one of the most aggressive, deadly, and treatment-resistant forms of cancer within the brain, with an average life expectancy of 12-18 months and more than 50,000 new cases each year The current standard of care for GBM is ineffective for approximately 60% of patients Initial Phase 1 trial information for Berubicin (approximately 14 years ago) resulted in one patient surviving cancer-free to present and two experiencing significant tumor reduction of up to 80% CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for brain tumors, recently participated in the…

Continue Reading

MondaySep 19, 2022 10:42 am

New Study Finds Hypertension Accelerates Bone Aging

A new study has found that high blood pressure (hypertension) may accelerate bone aging, as observed in mice models. The research was presented during this year’s Hypertension Scientific Sessions conference, hosted by the American Heart Association. The researchers’ objective was to understand how high blood pressure contributed to osteoporosis and help find ways to decrease the risk of the bone disease and better protect individuals from experiencing fragility fractures later in life. For their study, the researchers examined inflammation linked to hypertension in mice. This led to the discovery that high blood pressure may be linked to osteoporosis. Hypertension and…

Continue Reading

FridaySep 16, 2022 2:17 pm

The US Reaches One Million Organ Transplants

Last week, the United States clocked one million organ transplants. This historic milestone was confirmed by the United Network for Organ Sharing at 12.50 p.m. ET. This private nonprofit organization is in charge of managing the sole organ transplantation and procurement network in the United States, under contract with the federal government. Details about the patient who received this millionth organ are unknown. Additionally, it is unclear what organ brought the number to one million. The first successful organ transplant was carried out decades ago, in 1954. It was conducted at Boston’s Brigham and Women’s Hospital by Dr. Joseph Murray.…

Continue Reading

ThursdaySep 15, 2022 12:05 pm

Focused Ultrasound May Offer Easier Way to Treat Brain Tumors Effectively

Glioblastoma is an aggressive cancer that usually occurs in the spinal cord or the brain. While this cancer can occur at any age, it is more common in adults. The average life expectancy for patients with this type of cancer is between 12 to 15 months. Figures from the Glioblastoma Foundation show that while roughly 14,000 individuals are diagnosed with glioblastomas in America annually, less than 5% survive past the five-year mark. This cancer is usually treated with chemotherapy, surgery and radiation but has a high rate of recurrence, which means the tumors have a higher likelihood of coming back.…

Continue Reading

ThursdaySep 15, 2022 9:00 am

Odyssey Health, Inc.’s (ODYY) PRV-002 Drug Candidate Designed to Immediately Mitigate the Effects of Concussion on Brain Function

Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs The company is currently developing a treatment for concussion, a condition that currently does not have an FDA-approved treatment despite having both short- and long-term consequences Through animal studies, Odyssey has so far evidenced that PRV-002 can easily cross the blood-brain barrier to rapidly eliminate the swelling, oxidative stress, and inflammation in the brain caused by concussion while simultaneously restoring proper blood flow Odyssey is currently undertaking Phase 1 clinical studies with plans underway to commence its Phase 2 trial…

Continue Reading

WednesdaySep 14, 2022 11:05 am

Study Finds Depression Symptoms in Partners Caring for Dementia Patients May Start Long Before Cognitive Decline

A new study has found that symptoms of depression among older individuals who care for partners with cognitive impairments can present up to a decade before a routine screening can detect the first signs of their partner’s dementia. The research was carried out by scientists at the University of Michigan, including Geoffrey Hoffman, an assistant professor of nursing at the University of Michigan School of Nursing. These findings don’t align with current belief that there are significant increases in care received right after dementia begins developing. Hoffman stated that while conventional thinking suggested that the burden of caregiving and poor…

Continue Reading

TuesdaySep 13, 2022 1:53 pm

Study Finds Hepatitis C Drugs May Help Alleviate Symptoms of PTSD

Post-traumatic stress disorder (PTSD) is a debilitating mental condition that affects roughly 3.5% of American adults each year. Around 1 in 11 people will be diagnosed with the condition within their lifetime, with women being two times more likely to develop PTSD than men. PTSD is more prevalent in veterans, children and people who have been through traumatic events. But even though the condition affects millions of Americans each year, the FDA has only approved two drugs to treat it — paroxetine and sertraline — and these substances are only mildly effective against PTSD symptoms. For the past two years,…

Continue Reading

TuesdaySep 13, 2022 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Takes Aim at Thus-far Incurable GBM Brain Cancer with Human Drug Trials

U.S.-based drug innovator CNS Pharmaceuticals is enrolling patients in a global clinic trial to evaluate the performance of the company’s lead drug candidate, Berubicin, in fighting glioblastomas Glioblastoma is an incurable brain cancer that is aggressive in its progression and recurrence, leaving most patients with a life expectancy of less than a year after diagnosis CNS’s efforts to fill an unmet medical need arise from promise shown during Berubicin’s initial development by another company over 15 years ago, which included a small-scale human safety trial that produced a patient with no detectable cancer and others that saw tumor shrinkage and…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050